Commonwealth Equity Services
IHE icon

Commonwealth Equity Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Commonwealth Equity Services’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Sell
25,914
-790
-3% -$71.2K ﹤0.01% 1895
2026
Q1 		$2.31M Buy
26,704
+189
+0.7% +$16.5K ﹤0.01% 1882
2025
Q4 		$2.25M Sell
26,515
-2,619
-9% -$209K ﹤0.01% 1867
2025
Q3 		$2.11M Sell
29,134
-3,431
-11% -$237K ﹤0.01% 1954
2025
Q2 		$2.13M Sell
32,565
-4,279
-12% -$279K ﹤0.01% 1931
2025
Q1 		$2.6M Sell
36,844
-3,404
-8% -$237K ﹤0.01% 1722
2024
Q4 		$2.65M Buy
40,248
+2,106
+6% +$145K ﹤0.01% 1677
2024
Q3 		$2.69M Sell
38,142
-30
-0.1% -$2.09K ﹤0.01% 1616
2024
Q2 		$2.53M Buy
38,172
+2,589
+7% +$170K ﹤0.01% 1632
2024
Q1 		$2.42M Sell
35,583
-1,476
-4% -$97.6K ﹤0.01% 1650
2023
Q4 		$2.29M Sell
37,059
-2,433
-6% -$143K ﹤0.01% 1605
2023
Q3 		$2.33M Sell
39,492
-1,827
-4% -$112K ﹤0.01% 1509
2023
Q2 		$2.47M Buy
41,319
+474
+1% +$28.2K 0.01% 1488
2023
Q1 		$2.39K Buy
40,845
+849
+2% +$51.1K 0.01% 1453
2022
Q4 		$2.48M Buy
39,996
+3,471
+10% +$209K 0.01% 1363
2022
Q3 		$2.06M Sell
36,525
-1,311
-3% -$80.8K 0.01% 1398
2022
Q2 		$2.42M Sell
37,836
-1,782
-4% -$113K 0.01% 1314
2022
Q1 		$2.56M Sell
39,618
-1,020
-3% -$64.7K 0.01% 1342
2021
Q4 		$2.7M Sell
40,638
-5,151
-11% -$327K 0.01% 1293
2021
Q3 		$2.79M Sell
45,789
-156
-0.3% -$9.92K 0.01% 1214
2021
Q2 		$2.84M Buy
45,945
+777
+2% +$47.2K 0.01% 1196
2021
Q1 		$2.67M Sell
45,168
-114
-0.3% -$6.88K 0.01% 1133
2020
Q4 		$2.71M Buy
45,282
+21
+0% +$1.2K 0.01% 1048
2020
Q3 		$2.47M Buy
45,261
+819
+2% +$44.2K 0.01% 985
2020
Q2 		$2.28M Buy
44,442
+978
+2% +$49.2K 0.01% 972
2020
Q1 		$1.95M Sell
43,464
-2,391
-5% -$121K 0.01% 913
2019
Q4 		$2.45M Sell
45,855
-1,740
-4% -$85.8K 0.01% 926
2019
Q3 		$2.22M Sell
47,595
-3,612
-7% -$173K 0.01% 925
2019
Q2 		$2.57M Sell
51,207
-16,575
-24% -$819K 0.01% 844
2019
Q1 		$3.48M Buy
67,782
+4,281
+7% +$213K 0.02% 679
2018
Q4 		$2.98M Buy
63,501
+5,466
+9% +$280K 0.02% 659
2018
Q3 		$3.25M Sell
58,035
-660
-1% -$36.1K 0.02% 685
2018
Q2 		$2.96M Sell
58,695
-4,035
-6% -$200K 0.02% 707
2018
Q1 		$3.08M Sell
62,730
-5,532
-8% -$284K 0.02% 656
2017
Q4 		$3.51M Buy
68,262
+1,503
+2% +$77.2K 0.02% 593
2017
Q3 		$3.48M Sell
66,759
-1,140
-2% -$58.5K 0.02% 565
2017
Q2 		$3.51M Sell
67,899
-759
-1% -$38.4K 0.02% 542
2017
Q1 		$3.45M Buy
68,658
+3,054
+5% +$151K 0.02% 541
2016
Q4 		$3.09M Buy
65,604
+264
+0.4% +$12.5K 0.02% 550
2016
Q3 		$3.25M Sell
65,340
-3,117
-5% -$158K 0.03% 499
2016
Q2 		$3.29M Sell
68,457
-12,933
-16% -$615K 0.03% 480
2016
Q1 		$3.72M Sell
81,390
-2,655
-3% -$124K 0.03% 431
2015
Q4 		$4.53M Sell
84,045
-3,945
-4% -$208K 0.04% 357
2015
Q3 		$4.34M Buy
87,990
+3,231
+4% +$185K 0.05% 337
2015
Q2 		$4.94M Buy
84,759
+3,117
+4% +$182K 0.05% 336
2015
Q1 		$4.69M Buy
81,642
+3,318
+4% +$181K 0.05% 334
2014
Q4 		$3.95M Buy
78,324
+4,500
+6% +$219K 0.04% 360
2014
Q3 		$3.45M Buy
73,824
+9,597
+15% +$433K 0.04% 367
2014
Q2 		$2.89M Buy
64,227
+2,442
+4% +$105K 0.04% 427
2014
Q1 		$2.61M Buy
61,785
+4,806
+8% +$201K 0.04% 424
2013
Q4 		$2.24M Buy
56,979
+5,976
+12% +$224K 0.03% 460
2013
Q3 		$1.81M Sell
51,003
-1,926
-4% -$67.8K 0.03% 483
2013
Q2 		$1.76M Buy
+52,929
New +$1.76M 0.03% 457

Other funds holding IHE

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
AFG
Arkansas Financial Group Little Rock, Arkansas $768M AUM 16.55% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

Commonwealth Equity Services's IHE Position: Q2 2026 in Review

Commonwealth Equity Services reduced its iShares US Pharmaceuticals ETF (IHE) stake by 3% in Q2 2026, selling an estimated $71.2K and leaving 25,914 shares worth $2.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1895.

Commonwealth Equity Services first reported a position in IHE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.94M in Q2 2015. 77 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Commonwealth Equity Services held 25,914 shares of iShares US Pharmaceuticals ETF worth $2.57M as of Q2 2026.
  • Commonwealth Equity Services sold 790 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $71.2K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #1895 holding.
  • Commonwealth Equity Services first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 53 quarters since.
  • Commonwealth Equity Services's iShares US Pharmaceuticals ETF position peaked at $4.94M in Q2 2015.
  • 77 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.